Latest News

Dec 30, 2021

​Israel Biotech Fund

We are excited to step into 2022 together with IBF
https://israelbiotechfund.com/
Proud to be part of exclusive portfolio of innovative #lifesciences companies.
This funding accelerates the path towards clinical stage of our first-in-class biotherapy targeting cancers with p53 mutations.
We are on mission to bring cure to cancer patients.

​Israel Biotech Fund

Dec 11, 2021

Virtual MedInvest Oncology Investor Conference

This week ExoProTher Medical presented at the virtual MedInvest Oncology Investor Conference. ExoProTher’s Chief Executive Officer, Lana Volokh, delivered the corporate overview. She described the Company’s unique scientific foundation and technology and provided an update on program status. ExoProTher aims to significantly impact the way cancer is treated. Link to the presentation recording: https://youtu.be/JxwwiSTyrwk

Virtual MedInvest Oncology Investor Conference

Oct 6, 2021

PAT-ICRS workshop

Presenting our latest results at the PAT-ICRS workshop.

PAT-ICRS workshop

Jul 8, 2021

In lab Investors event

Investors event in our R&D Lab at Colab square Yokneam, taking a glimpse into the digital microscope along with markers on milestones achieved.

In lab Investors event

Jun 23, 2021

New R&D lab at Colab Square Facility, Yokneam

Beginning May 2021, ExoProTher is operating a new R&D lab situated at unique Colab Square facility in Yokneam Industrial park. ExoProTher is joining a line of exciting and promising biotech companies.

The combination of location, equipment and environment allow to boost R&D activities and attract top talent to the expanding team.

New R&D lab at Colab Square Facility, Yokneam

Jun 16, 2021

2021 Virtual World Stem Cell Summit

ExoProTher Medical - Co-founder & CEO Dr. Lana Volokh
at The Investor Forum - at the 2021 Virtual World Stem Cell Summit. (hosted by channelchek)

2021 Virtual World Stem Cell Summit

May 17, 2021

SEV2021 Annual Meeting


SEV2021 Annual Meeting
ExoProTher's scientific abstract reporting our recent preclinical results at the Annual Meeting of International Society for Extracellular Vesicles.

SEV2021 Annual Meeting

Mar 9, 2021

Magische kugel against cancer

"Magic bullet against cancer"



Short Communication - Journal of Molecular Oncology Research (2021) Volume 5, Issue 2

Magische kugel against cancer

Jan 5, 2021

New media coverage - Globes article featuring ExoProTher

ExoProTher article in Israeli business daily the "Globes".


Hebrew article by Globes' biomed reporter, Gali Weinreb.

New media coverage - Globes article featuring ExoProTher

Jan 4, 2021

Startup World Cup

ExoProTher is honored to be selected among top ten Israeli companies in the largest startup competition in the world - Startup World Cup.



Best regards,

Lana Volokh - CEO

Startup World Cup

Nov 11, 2020

ExoProTher milestone achieved

I am pleased to share with our followers and investors the latest in vivo results.



Two weeks ago, a successful in vivo experiment on mouse model of colon cancer ended with impressive results. Life span of treated mice was significantly prolonged after single dose of Exo, while 25% of them remained tumor-free after the experiment completion. Additional in vivo studies using other cancer models are in progress.



Best regards,

Lana Volokh - CEO

ExoProTher milestone achieved

Sep 12, 2020

New recruits & Additional facility

Exciting growth period for ExoProTher Medical: we opened a new laboratory facility and brought on board new talent.



The new laboratory started functioning in Shlomi, Israel. It will focus on optimizing production and characterization of EXO_ compounds.



With extended R&D team, we continue to broaden and deepen our research capabilities.

New recruits & Additional facility

Feb 25, 2020

SoCal
Startup Day

Velocity on the rise not only in our labs.

Great boost coming from amazing crowd engagement in the SoCal startup event.

SoCal
Startup Day

Feb 25, 2020

SoCal
Startup Day

We are excited to attend the SoCal Startup Day and present our development.
Come see our quick-fire presentation as part of the start-up competition and visit us at booth #22 to learn more about our unique approach.

SoCal
Startup Day

Feb 4, 2020

@Tel-Aviv stock exchange

ExitValley and Eternity Capital investors event at the Tel-Aviv stock exchange.

@Tel-Aviv stock exchange

Dec 11, 2019

Call for Action

ExoProTher VP Business Development update and call for action.

Call for Action

Dec 8, 2019

ExitValley's campaign

About a week into the campaign and the traction is high,

More than 100% of initial funding target.

ExitValley's campaign

Dec 1, 2019

ExitValley's Investors meeting

What a great event to be part of – first ExitValley’s Investors meeting!

Dr. Alex Tendler, co-founder and CTO of ExoProTher Medical, presented our unique concept and its outstanding potential to the very interested audience.



Excellent traction,

ExoProTher Medical launched the crowdfunding campaign using ExitValley platform.


It is super cool to see first investment after less than 12 hours. Amazing start.

ExitValley's Investors meeting

Aug 31, 2019

TheMarker's OncoTalk publication


TheMarker's OncoTalk
publication
Harness evolution to fight cancer

OncoTalk's brief - exposing ExoProTher innovative approach

TheMarker's OncoTalk publication